500727 Immunmodulation (S) (WiSe 2023/2024)

Short comment

Pharmakologie und Pharmakotherapie

Contents, comment

Diese Veranstaltung ist Teil des Clusters "Blut und Immunsystem und solide Tumoren", den Link zum Lernraum finden Sie hier: https://moodle.uni-bielefeld.de/course/view.php?id=1806

Studierende 43-60

  • konventionelle synthetische Hemmstoffe des IMmunsystems: Methotrexat , Leflunomid , Sulfasalazin , Chloroquin, Hydroxychloroquin, Ciclosporin , Azathioprin
  • Kinase Inhibitoren: Baricitinib, Tofacitinib
  • Zytokinantagonisten:: Adalimumab , Infliximab, Etanercept , Abatacept , Anakinra 
  • TOR-Inhibitoren: Sirolimus, Everolimus
  •  Antikörper gegen Interleukin-2-Rezeptor auf aktivierten T-Lymphozyten: Basiliximab :
  • Antikörper gegen CD52 auf B- und T-Zellen: Alemtuzumab :
  • Antikörper gegen CD20 auf B-Zellen: Rituximab 
  • Checkpointinhibitor . Antikörper gegen PD1-Rezeptor: Pembrolizumab 


Besprochen werden klassische und neue Medikamente, die das Immunsystem modulieren und beispilesweise bei der Behandlung von entzündlichen Erkrankungen des Zentralen Nervensystems verwendet werden.

Bibliography

Vorausgesetzt wird der Besuch der Vorlesungen Physiologie des Immunsystems im 4. Fachsemester.
Bitte lesen Sie vor dem Seminar das Kapitel Antirheumatische, immunsuppressive und zytostatische Therapie in Dellas, Last Minute Pharmakologie. Urban & Fischer /Elsevier. (https://katalogplus.ub.uni-bielefeld.de/Record/991025992240506442)

Teaching staff

Managed course

Participation in this course is managed by the Medical Faculty OWL, you cannot add it to your timetable yourself. If necessary, please contact the examination office at this address: pruefungsamt.medizin@uni-bielefeld.de

Dates ( Calendar view )

Frequency Weekday Time Format / Place Period  

Show passed dates >>

Subject assignments

Module Course Requirements  
5-I-R-T Regulation I Regulation I (Seminar) Student information

The binding module descriptions contain further information, including specifications on the "types of assignments" students need to complete. In cases where a module description mentions more than one kind of assignment, the respective member of the teaching staff will decide which task(s) they assign the students.

No more requirements
No eLearning offering available
Registered number: 18
This is the number of students having stored the course in their timetable. In brackets, you see the number of users registered via guest accounts.
eKVV participant management:
eKVV participant management is used for this course.
Show details
Limitation of the number of participants:
Limited number of participants: 18
Address:
WS2023_500727@ekvv.uni-bielefeld.de
This address can be used by teaching staff, their secretary's offices as well as the individuals in charge of course data maintenance to send emails to the course participants. IMPORTANT: All sent emails must be activated. Wait for the activation email and follow the instructions given there.
If the reference number is used for several courses in the course of the semester, use the following alternative address to reach the participants of exactly this: VST_437846760@ekvv.uni-bielefeld.de
Coverage:
18 Students to be reached directly via email
Notes:
Additional notes on the electronic mailing lists
Last update basic details/teaching staff:
Friday, September 15, 2023 
Last update times:
Monday, October 9, 2023 
Last update rooms:
Friday, September 15, 2023 
Type(s) / SWS (hours per week per semester)
seminar (S) /
Department
University Medical Center OWL / Evangelisches Klinikum Bethel
Questions or corrections?
Questions or correction requests for this course?
Planning support
Clashing dates for this course
Links to this course
If you want to set links to this course page, please use one of the following links. Do not use the link shown in your browser!
The following link includes the course ID and is always unique:
https://ekvv.uni-bielefeld.de/kvv_publ/publ/vd?id=437846760
Send page to mobile
Click to open QR code
Scan QR code: Enlarge QR code
ID
437846760